O'Shaughnessy Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,870
Closed -$204K 2754
2026
Q1
$204K Buy
+1,870
New +$178K ﹤0.01% 1982
2025
Q4
Sell
-2,456
Closed -$215K 2704
2025
Q3
$215K Buy
+2,456
New +$219K ﹤0.01% 1932
2025
Q2
Sell
-3,010
Closed -$253K 2457
2025
Q1
$253K Buy
3,010
+123
+4% +$11.4K ﹤0.01% 1677
2024
Q4
$266K Buy
2,887
+97
+3% +$9.33K ﹤0.01% 1599
2024
Q3
$257K Buy
2,790
+38
+1% +$3.29K ﹤0.01% 1550
2024
Q2
$226K Buy
+2,752
New +$202K ﹤0.01% 1494
2021
Q4
Sell
-1,336
Closed -$71K 1920
2021
Q3
$71K Buy
1,336
+1,192
+828% +$67.1K ﹤0.01% 1512
2021
Q2
$9K Buy
+144
New +$7.65K ﹤0.01% 2016

Other funds holding LMAT

O'Shaughnessy Asset Management's LMAT Position: Q2 2026 in Review

O'Shaughnessy Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,870 shares — an estimated $204K sold.

O'Shaughnessy Asset Management first reported a position in LMAT in Q2 2021 and held it in 8 quarters. The position peaked at $266K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • O'Shaughnessy Asset Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,870 LeMaitre Vascular shares in Q2 2026, an estimated $204K.
  • O'Shaughnessy Asset Management first reported a position in LeMaitre Vascular in Q2 2021 and held it in 8 quarters.
  • O'Shaughnessy Asset Management's LeMaitre Vascular position peaked at $266K in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.